Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,503 | 0 | -2,860 | -2,030 | 0 |
| Depreciation Amortization | 4 | 0 | N/A | 0 | 0 |
| Accounts receivable | 110 | N/A | 58 | N/A | N/A |
| Accounts payable and accrued liabilities | -174 | N/A | -210 | N/A | N/A |
| Other Working Capital | -147 | 0 | N/A | 0 | 0 |
| Other Operating Activity | 785 | 0 | 542 | 240 | -1,340 |
| Operating Cash Flow | $-925 | $0 | $-2,470 | $-1,790 | $-1,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | 0 | -8 | -10 | 0 |
| Sale Of Investment | 20 | N/A | 291 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -2 | N/A | N/A |
| Other Investing Activity | -11 | 0 | 1,207 | 990 | 810 |
| Investing Cash Flow | $7 | $0 | $1,490 | $980 | $810 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,559 | N/A | 309 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -9 | 300 | 290 |
| Financing Cash Flow | $3,559 | $0 | $300 | $300 | $290 |
| Exchange Rate Effect | 20 | 0 | -10 | -500 | 10 |
| Beginning Cash Position | 2,159 | 0 | 2,880 | 2,880 | 2,880 |
| End Cash Position | 4,820 | 0 | 2,150 | 2,360 | 2,670 |
| Net Cash Flow | $2,661 | $0 | $-720 | $-520 | $-210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -925 | 0 | -2,470 | -1,790 | -1,340 |
| Capital Expenditure | -2 | N/A | -8 | N/A | N/A |
| Free Cash Flow | -927 | 0 | -2,478 | -1,790 | -1,340 |